Skip to main content

Table 1 Correlation of CSNK1D expression with clinical features in 110 HCC patients

From: Circadian gene CSNK1D promoted the progression of hepatocellular carcinoma by activating Wnt/β-catenin pathway via stabilizing Dishevelled Segment Polarity Protein 3

Parameters

n

CSNK1D expression

P

 

Low

High

 

Sex

   

0.065

Male

93

43

50

 

Female

17

12

5

 

Age

   

0.335

 < 50

63

29

34

 

 ≥ 50

47

26

21

 

AFP(ng/ml)

   

0.175

 < 400

65

36

29

 

 ≥ 400

45

19

26

 

Tumor size

   

0.01

 < 5 cm

41

27

14

 

 ≥ 5 cm

69

28

41

 

Differentiation

   

 < 0.001

Well

35

32

3

 

Moderate & Poor

75

23

52

 

Microvascular Invasion

   

0.021

Yes

24

7

17

 

No

86

48

38

 

TNM stage

   

 < 0.001

I-II

39

30

9

 

III-IV

71

25

46

 

Tumor number

   

0.825

Single

83

41

42

 

Multiple

27

14

13

 

HBV-DNA

   

0.849

 < 1000

55

28

27

 

 ≥ 1000

55

27

28

 

Liver cirrhosis

   

0.563

Yes

63

33

30

 

No

47

22

25

 

Metastasis

   

0.012

Yes

6

0

6

 

No

104

55

49

 

Recurrence

   

0.008

Yes

52

19

33

 

No

58

36

22

 
  1. AFP alpha-fetoprotein, TNM tumor-node-metastasis